Recent News
On October 9, 2025 the company set its second-quarter fiscal 2026 results release for November 6, 2025. On November 6, 2025 Haemonetics published second-quarter fiscal 2026 financial results and hosted a related conference call and webcast. In mid-November analysts revised the one-year price target higher, with the average target rising to $88.03 on November 17, 2025. Investor’s Business Daily reported improved relative strength metrics and noted a cup-without-handle pattern forming in the stock during November 2025.
Technical Analysis
ADX and Directional Indicators: ADX at 61.79 signals a very strong trend environment; the directional structure shows DI+ at 44.44 in a peak-and-reversal pattern (bearish) while DI- at 6.85 decreased (bullish). Taken together, trend strength remains high but the directional indices show a recent loss of upside dominance that raises the probability of short-term mean reversion toward valuation levels.
MACD: MACD at 6.34 currently sits above the signal line at 6.01, producing a bullish crossover signal, while the MACD trend shows a peak-and-reversal, which signals contracting bullish momentum. The combination implies the prior upward momentum may be losing steam despite the recent bullish crossover.
MRO (Momentum/Regression Oscillator): MRO registers 34.87 with a peak-and-reversal trend; the positive value indicates price sits above modeled target and the peak-and-reversal warns of increased downside pressure relative to the current valuation target.
RSI and Momentum: RSI at 68.77 with an increasing trend indicates near-overbought conditions and continued buying interest; the rising RSI supports near-term momentum but also raises the risk of a pullback if momentum reverses.
Price Versus Averages and Support: Last close at $81.91 sits above the 20-day average ($77.95), 50-day average ($59.78) and 200-day average ($63.51), reflecting a sustained uptrend. The super trend lower at $76.59 and the 12-day EMA rising to $78.00 provide near-term support zones that align with the MRO signal suggesting upside may be capped near current levels.
Ichimoku / Volatility: Price trades above the Kijun-sen ($65.70) and Tenkan-sen ($77.17) with Senkou span values supportive of price, reinforcing the bullish longer-term bias while short-term momentum indicators show divergence. Volatility registers modestly higher over the 42-day window, consistent with the recent strong trend.
Fundamental Analysis
Profitability: EBIT at $58,491,000 and EBITDA at $86,746,000 produce an EBIT margin of 17.87%, below the industry peer mean of 19.89%. Operating margin stands at 20.49%, which improved QoQ by 22.25% and YoY by 36.96%, demonstrating margin expansion that supports the company’s valuation despite the EBIT margin remaining slightly below the industry peer mean.
Earnings and Cash Flow: Reported EPS of $1.27 exceeded the $1.11 estimate by $0.16, an EPS surprise of 14.41%. Free cash flow totaled $106,305,000 with a free cash flow yield of 4.23%, above the industry peer mean of 0.90%, indicating strong cash generation relative to peers.
Growth and Revenue Dynamics: Revenue growth YoY declined by 33.69%, while earnings growth YoY rose 57.64%, reflecting margin improvement and cost leverage offsetting top-line contraction. Revenue per share stands at $7.00 and forward revenue is $132,011,903.
Balance Sheet and Leverage: Market capitalization equals $2,510,684,965 while enterprise value sits at $3,438,986,965, leaving net debt at $928,302,000. Debt-to-equity measures 1.44, above the industry peer mean of 0.63, and debt-to-EBITDA equals 14.12, signaling elevated leverage that constrains flexibility despite strong interest coverage (~8.12x).
Working Capital and Efficiency: Cash conversion cycle at 264.93 days exceeds the industry peer mean of 193.39 days, indicating slower working capital turnover. Asset turnover at 0.133 slightly outperforms the industry peer mean of 0.125, showing modest efficiency gains.
Valuation Summary: Price multiples show a PE of 42.29 and forward PE of 43.79; price-to-book equals 2.96, below the industry peer mean of 6.41. Enterprise multiple stands at 39.64. The current valuation as determined by WMDST places the stock as under-valued, supported by above-mean free cash flow yield and a below-mean price-to-book, although elevated leverage and contracted revenue growth temper the margin of safety.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-09-30 |
| REPORT DATE: | 2025-11-06 |
| NEXT REPORT DATE: | 2026-02-05 |
| CASH FLOW | Begin Period Cash Flow | $ 292.9 M |
| Operating Cash Flow | $ 111.3 M | |
| Capital Expenditures | $ -5.02 M | |
| Change In Working Capital | $ 26.1 M | |
| Dividends Paid | — | |
| Cash Flow Delta | $ 3.5 M | |
| End Period Cash Flow | $ 296.4 M | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | $ 327.3 M | |
| Forward Revenue | $ 132.0 M | |
| COSTS | ||
| Cost Of Revenue | $ 132.6 M | |
| Depreciation | $ 17.1 M | |
| Depreciation and Amortization | $ 28.3 M | |
| Research and Development | $ 14.9 M | |
| Total Operating Expenses | $ 260.2 M | |
| PROFITABILITY | ||
| Gross Profit | $ 194.7 M | |
| EBITDA | $ 86.7 M | |
| EBIT | $ 58.5 M | |
| Operating Income | $ 67.1 M | |
| Interest Income | — | |
| Interest Expense | $ 7.2 M | |
| Net Interest Income | $ -7.21 M | |
| Income Before Tax | $ 51.3 M | |
| Tax Provision | $ 12.6 M | |
| Tax Rate | 24.6 % | |
| Net Income | $ 38.7 M | |
| Net Income From Continuing Operations | $ 38.7 M | |
| EARNINGS | ||
| EPS Estimate | $ 1.11 | |
| EPS Actual | $ 1.27 | |
| EPS Difference | $ 0.16 | |
| EPS Surprise | 14.414 % | |
| Forward EPS | $ 1.33 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | $ 2.4 B | |
| Intangible Assets | $ 1.0 B | |
| Net Tangible Assets | $ -185.28 M | |
| Total Current Assets | $ 899.7 M | |
| Cash and Short-Term Investments | $ 296.4 M | |
| Cash | $ 296.4 M | |
| Net Receivables | $ 207.1 M | |
| Inventory | $ 336.2 M | |
| Long-Term Investments | $ 208.0 M | |
| LIABILITIES | ||
| Accounts Payable | $ 61.7 M | |
| Short-Term Debt | $ 304.3 M | |
| Total Current Liabilities | $ 548.3 M | |
| Net Debt | $ 928.3 M | |
| Total Debt | $ 1.2 B | |
| Total Liabilities | $ 1.6 B | |
| EQUITY | ||
| Total Equity | $ 849.2 M | |
| Retained Earnings | $ 336.3 M | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | $ 18.17 | |
| Shares Outstanding | 46.747 M | |
| Revenue Per-Share | $ 7.00 | |
| VALUATION | Market Capitalization | $ 2.5 B |
| Enterprise Value | $ 3.4 B | |
| Enterprise Multiple | 39.644 | |
| Enterprise Multiple QoQ | -18.886 % | |
| Enterprise Multiple YoY | -10.37 % | |
| Enterprise Multiple IPRWA | high: 161.723 median: 104.027 mean: 88.345 HAE: 39.644 low: -110.323 |
|
| EV/R | 10.507 | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | 2.876 | |
| Asset To Liability | 1.533 | |
| Debt To Capital | 0.591 | |
| Debt To Assets | 0.501 | |
| Debt To Assets QoQ | 0.81 % | |
| Debt To Assets YoY | 23225.116 % | |
| Debt To Assets IPRWA | high: 0.737 HAE: 0.501 median: 0.333 mean: 0.314 low: 0.002 |
|
| Debt To Equity | 1.442 | |
| Debt To Equity QoQ | 3.896 % | |
| Debt To Equity YoY | 23237.54 % | |
| Debt To Equity IPRWA | high: 2.338 HAE: 1.442 mean: 0.633 median: 0.531 low: 0.002 |
|
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | 2.957 | |
| Price To Book QoQ | -16.03 % | |
| Price To Book YoY | -32.905 % | |
| Price To Book IPRWA | high: 12.447 median: 6.636 mean: 6.407 HAE: 2.957 low: -4.114 |
|
| Price To Earnings (P/E) | 42.289 | |
| Price To Earnings QoQ | -35.684 % | |
| Price To Earnings YoY | -38.383 % | |
| Price To Earnings IPRWA | high: 256.954 mean: 126.179 median: 118.26 HAE: 42.289 low: -227.904 |
|
| PE/G Ratio | 2.736 | |
| Price To Sales (P/S) | 7.671 | |
| Price To Sales QoQ | -20.645 % | |
| Price To Sales YoY | -31.567 % | |
| Price To Sales IPRWA | high: 77.674 mean: 33.395 median: 29.418 HAE: 7.671 low: 0.679 |
|
| FORWARD MULTIPLES | ||
| Forward P/E | 43.788 | |
| Forward PE/G | 2.833 | |
| Forward P/S | 19.019 | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | 4.654 | |
| ASSET & SALES | ||
| Asset Turnover Ratio | 0.133 | |
| Asset Turnover Ratio QoQ | 2.026 % | |
| Asset Turnover Ratio YoY | -2.141 % | |
| Asset Turnover Ratio IPRWA | high: 0.417 HAE: 0.133 median: 0.127 mean: 0.125 low: 0.001 |
|
| Receivables Turnover | 1.605 | |
| Receivables Turnover Ratio QoQ | 0.741 % | |
| Receivables Turnover Ratio YoY | -3.594 % | |
| Receivables Turnover Ratio IPRWA | high: 3.935 mean: 1.837 median: 1.771 HAE: 1.605 low: 0.627 |
|
| Inventory Turnover | 0.381 | |
| Inventory Turnover Ratio QoQ | 6.911 % | |
| Inventory Turnover Ratio YoY | -9.012 % | |
| Inventory Turnover Ratio IPRWA | high: 2.068 mean: 0.534 median: 0.473 HAE: 0.381 low: 0.09 |
|
| Days Sales Outstanding (DSO) | 56.846 | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | 264.935 | |
| Cash Conversion Cycle Days QoQ | 1.707 % | |
| Cash Conversion Cycle Days YoY | 16.545 % | |
| Cash Conversion Cycle Days IPRWA | high: 409.199 HAE: 264.935 median: 201.455 mean: 193.387 low: -109.842 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | 0.932 | |
| CapEx To Revenue | -0.015 | |
| CapEx To Depreciation | -0.294 | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | $ 1.8 B | |
| Net Invested Capital | $ 2.1 B | |
| Invested Capital | $ 2.1 B | |
| Net Tangible Assets | $ -185.28 M | |
| Net Working Capital | $ 351.4 M | |
| LIQUIDITY | ||
| Cash Ratio | 0.541 | |
| Current Ratio | 1.641 | |
| Current Ratio QoQ | -4.515 % | |
| Current Ratio YoY | -52.977 % | |
| Current Ratio IPRWA | high: 14.251 mean: 2.768 median: 1.703 HAE: 1.641 low: 0.159 |
|
| Quick Ratio | 1.028 | |
| Quick Ratio QoQ | -1.183 % | |
| Quick Ratio YoY | -50.938 % | |
| Quick Ratio IPRWA | high: 13.711 mean: 2.03 median: 1.123 HAE: 1.028 low: 0.317 |
|
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | 14.119 | |
| Cost Of Debt | 0.444 % | |
| Interest Coverage Ratio | 8.117 | |
| Interest Coverage Ratio QoQ | 31.13 % | |
| Interest Coverage Ratio YoY | 9.798 % | |
| Interest Coverage Ratio IPRWA | high: 119.631 median: 19.958 mean: 17.831 HAE: 8.117 low: -165.333 |
|
| Operating Cash Flow Ratio | 0.184 | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | 38.048 | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | -0.81 % | |
| Revenue Growth | 1.842 % | |
| Revenue Growth QoQ | -166.164 % | |
| Revenue Growth YoY | -33.693 % | |
| Revenue Growth IPRWA | high: 27.485 % HAE: 1.842 % mean: 1.404 % median: 0.122 % low: -22.33 % |
|
| Earnings Growth | 15.455 % | |
| Earnings Growth QoQ | -236.891 % | |
| Earnings Growth YoY | 57.64 % | |
| Earnings Growth IPRWA | high: 105.556 % HAE: 15.455 % mean: 13.261 % median: 7.609 % low: -86.957 % |
|
| MARGINS | ||
| Gross Margin | 59.497 % | |
| Gross Margin QoQ | -0.533 % | |
| Gross Margin YoY | 9.674 % | |
| Gross Margin IPRWA | high: 94.036 % median: 64.812 % mean: 64.321 % HAE: 59.497 % low: -17.483 % |
|
| EBIT Margin | 17.87 % | |
| EBIT Margin QoQ | 6.61 % | |
| EBIT Margin YoY | 19.436 % | |
| EBIT Margin IPRWA | high: 82.825 % median: 19.944 % mean: 19.889 % HAE: 17.87 % low: -487.428 % |
|
| Return On Sales (ROS) | 20.492 % | |
| Return On Sales QoQ | 22.253 % | |
| Return On Sales YoY | 36.96 % | |
| Return On Sales IPRWA | high: 69.921 % mean: 20.563 % HAE: 20.492 % median: 19.944 % low: -487.428 % |
|
| CASH FLOW | ||
| Free Cash Flow (FCF) | $ 106.3 M | |
| Free Cash Flow Yield | 4.234 % | |
| Free Cash Flow Yield QoQ | 864.465 % | |
| Free Cash Flow Yield YoY | 316.323 % | |
| Free Cash Flow Yield IPRWA | high: 5.888 % HAE: 4.234 % mean: 0.901 % median: 0.733 % low: -18.664 % |
|
| Free Cash Growth | 679.305 % | |
| Free Cash Growth QoQ | -885.478 % | |
| Free Cash Growth YoY | -410.063 % | |
| Free Cash Growth IPRWA | HAE: 679.305 % high: 185.61 % median: 25.615 % mean: 21.616 % low: -192.298 % |
|
| Free Cash To Net Income | 2.748 | |
| Cash Flow Margin | 30.743 % | |
| Cash Flow To Earnings | 2.601 | |
| VALUE & RETURNS | ||
| Economic Value Added | $ 0.03 | |
| Return On Assets (ROA) | 1.578 % | |
| Return On Assets QoQ | 13.935 % | |
| Return On Assets YoY | 18.114 % | |
| Return On Assets IPRWA | high: 5.043 % mean: 1.899 % median: 1.792 % HAE: 1.578 % low: -36.008 % |
|
| Return On Capital Employed (ROCE) | 3.088 % | |
| Return On Equity (ROE) | 0.046 | |
| Return On Equity QoQ | 18.097 % | |
| Return On Equity YoY | 18.342 % | |
| Return On Equity IPRWA | high: 0.068 HAE: 0.046 median: 0.037 mean: 0.028 low: -0.624 |
|
| DuPont ROE | 4.468 % | |
| Return On Invested Capital (ROIC) | 2.127 % | |
| Return On Invested Capital QoQ | 10.436 % | |
| Return On Invested Capital YoY | -115.971 % | |
| Return On Invested Capital IPRWA | high: 5.308 % median: 2.535 % mean: 2.485 % HAE: 2.127 % low: -14.919 % |
|